Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
EMEA | | | | 1,746.9 | 1,801.9 | 1,745.2 | | 1,250.7 |
Other | | | | 6,235.3 | 6,131.0 | 6,058.1 | | 4,747.1 |
Total revenues [+] | 6,939.9 | 6,827.3 | 6,127.5 | 7,982.2 | 7,932.9 | 7,803.3 | 7,668.4 | 5,997.8 |
Products | | | | 7,982.2 | 7,932.9 | 7,803.3 | | 5,997.8 |
Revenue growth [+] | 1.6% | 11.4% | -23.2% | 0.6% | 1.7% | 1.8% | 27.9% | 28.3% |
EMEA | | | | -3.1% | 3.2% | | | 5.2% |
Cost of goods sold | 2,019.5 | 1,960.4 | 1,824.3 | 2,252.6 | 2,271.9 | 2,132.9 | 2,381.8 | 1,800.6 |
Gross profit | 4,920.4 | 4,866.9 | 4,303.2 | 5,729.6 | 5,661.0 | 5,670.4 | 5,286.6 | 4,197.2 |
Gross margin | 70.9% | 71.3% | 70.2% | 71.8% | 71.4% | 72.7% | 68.9% | 70.0% |
Selling, general and administrative | 698.8 | 452.1 | 825.8 | 3,343.8 | 3,379.3 | 3,104.7 | 2,944.6 | 2,284.2 |
Research and development | 406.0 | 435.8 | 322.8 | 449.3 | 391.7 | 369.9 | 365.6 | 268.8 |
Other operating expenses | 2,957.6 | 3,244.7 | 2,563.7 | 728.9 | 876.5 | 1,065.0 | 1,124.2 | 2,016.4 |
EBITDA [+] | 1,784.4 | 1,672.0 | 1,489.3 | 2,213.7 | 2,054.0 | 2,193.5 | 1,891.5 | 340.2 |
EBITDA growth | 6.7% | 12.3% | -32.7% | 7.8% | -6.4% | 16.0% | 456.0% | -68.9% |
EBITDA margin | 25.7% | 24.5% | 24.3% | 27.7% | 25.9% | 28.1% | 24.7% | 5.7% |
Depreciation | 399.6 | 408.2 | 386.3 | 421.8 | 444.6 | 458.8 | 473.4 | 375.0 |
EBITA | 1,384.8 | 1,263.8 | 1,103.0 | 1,791.9 | 1,609.4 | 1,734.7 | 1,418.1 | -34.8 |
EBITA margin | 20.0% | 18.5% | 18.0% | 22.4% | 20.3% | 22.2% | 18.5% | -0.6% |
Amortization of intangibles | 526.8 | 529.5 | 512.1 | 584.3 | 595.9 | 603.9 | 565.9 | 337.4 |
EBIT [+] | 858.0 | 734.3 | 590.9 | 1,207.6 | 1,013.5 | 1,130.8 | 852.2 | -372.2 |
EBIT growth | 16.8% | 24.3% | -51.1% | 19.2% | -10.4% | 32.7% | -329.0% | -151.9% |
EBIT margin | 12.4% | 10.8% | 9.6% | 15.1% | 12.8% | 14.5% | 11.1% | -6.2% |
Non-recurring items [+] | 292.8 | 16.3 | 503.0 | 70.1 | 979.7 | 331.5 | 31.1 | -839.5 |
Asset impairment | 292.8 | 16.3 | 503.0 | 70.1 | 979.7 | 331.5 | 31.1 | |
Unusual expense | | | | | | | | -839.5 |
Interest expense, net [+] | 161.7 | 219.0 | 193.1 | 193.1 | 282.8 | 317.5 | 363.1 | 484.3 |
Interest expense | 161.7 | 219.0 | 193.1 | 193.1 | 282.8 | 317.5 | 363.1 | 493.7 |
Interest income | | | | | | | | 9.4 |
Other income (expense), net | | | | -38.6 | -22.1 | -17.2 | -58.4 | 170.2 |
Pre-tax income | 403.5 | 499.0 | -105.2 | 905.8 | -271.1 | 464.6 | 399.6 | 153.2 |
Income taxes | 112.3 | 53.5 | -96.0 | -225.7 | 108.2 | -1,348.8 | 95.0 | 7.0 |
Tax rate | 27.8% | 10.7% | 91.3% | | | | 23.8% | 4.6% |
Minority interest | | | | -0.1 | -0.1 | -0.4 | -1.3 | -0.8 |
Earnings from continuing ops | 290.2 | 445.0 | -10.7 | 1,131.6 | -379.2 | 1,813.8 | 305.9 | 147.0 |
Earnings from discontinued ops | -58.8 | -43.4 | -128.2 | | | | | |
Net income | 231.4 | 401.6 | -138.9 | 1,131.6 | -379.2 | 1,813.8 | 305.9 | 147.0 |
Net margin | 3.3% | 5.9% | -2.3% | 14.2% | -4.8% | 23.2% | 4.0% | 2.5% |
|
Basic EPS [+] | $1.38 | $2.13 | ($0.05) | $5.52 | ($1.86) | $8.98 | $1.53 | $0.78 |
Growth | -35.1% | -4227.0% | -100.9% | -396.1% | -120.7% | 487.4% | 95.0% | -81.6% |
Diluted EPS [+] | $1.38 | $2.12 | ($0.05) | $5.47 | ($1.86) | $8.90 | $1.51 | $0.77 |
Growth | -34.8% | -4191.7% | -100.9% | -393.8% | -120.9% | 489.2% | 95.1% | -81.5% |
|
Dividends per share [+] | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.96 | $0.88 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.1% | 0.0% |
|
Shares outstanding (basic) [+] | 209.6 | 208.6 | 207.0 | 205.1 | 203.5 | 201.9 | 200.0 | 187.4 |
Growth | 0.5% | 0.8% | 0.9% | 0.8% | 0.8% | 1.0% | 6.7% | 10.9% |
Shares outstanding (diluted) [+] | 210.3 | 210.4 | 207.0 | 206.7 | 203.5 | 203.7 | 202.4 | 189.8 |
Growth | 0.0% | 1.6% | 0.1% | 1.6% | -0.1% | 0.6% | 6.6% | 10.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|